Brand Name(s): Cloraze Caps; Cloraze Tabs; GenENE;
Tranxene; Tranxene-SD
CAS nº: 57109-90-7
(klor AH zeh pate)
About Clorazepate
This new site is dedicated exclusively to clorazepate.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about clorazepate on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total clorazepate experience!
Why is this medication prescribed?
Clorazepate is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It works by enhancing the effects of a certain natural chemical in the body (GABA).
Clorazepate is used to relieve anxiety, nervousness, and tension associated with anxiety disorders. This medicine is also used to reduce symptoms associated with alcohol withdrawal, and to treat certain types of seizures.
It is marketed under brand name Tranxene®, amongst others.
Latest News
Mylan Says It Will Appeal Court Decision In Last Of Lorazepam And Clorazepate Antitrust Cases
Friday, Mylan Inc. (MYL), a developer of Pharmaceutical ingredients, said that it intends to appeal...
[more]The twin effects of anxiety and fear
"Our fear is keeping the drug industry booming," so stated the Reverend Dr Robert Thompson,...
[more]Virtual reality to the rescue
Therapists are turning to technology to help people overcome their deepest fears and anxieties
[more]Trial Victory in Lorazepam and Clorazepate Antitrust Litigation
Analysis Group Managing Principal Atanu Saha provided expert testimony on liability and damages...
[more]Ranbaxy Receives USFDA Approval to Market Clorazepate Dipotassium Tablets USP
Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has received approval from...
[more]